# Clinical Exploration Study of YOLT-203 in the Treatment of Type 1 Primary Hyperoxaluria (PH1)

> **NCT06892301** · EARLY_PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Guangzhou Women and Children's Medical Center** · enrollment: 2 (estimated)

## Conditions studied

- Type 1 Primary Hyperoxaluria

## Interventions

- **DRUG:** YOLT-203

## Key facts

- **NCT ID:** NCT06892301
- **Lead sponsor:** Guangzhou Women and Children's Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-02-27
- **Primary completion:** 2026-07
- **Final completion:** 2026-07
- **Target enrollment:** 2 (ESTIMATED)
- **Last updated:** 2025-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06892301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06892301, "Clinical Exploration Study of YOLT-203 in the Treatment of Type 1 Primary Hyperoxaluria (PH1)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06892301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*